BioTechX USA 2025

BioTechX USA 2025 is organized by Terrapinn Holdings Ltd and will be held from Sep 16 - 17, 2025 at Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States of America.

Description:
Covering diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare. America’s most exciting biotechnology congress, bridging the gap between pharma, academia and clinicians to foster meaningful collaborations

AI in Drug Discovery and Development

• Advances in AI for drug development
• AI in clinical trials
• Limitations of AI in drug development
• Data expansion in AI

LLMs

• Applications of LLMs in Drug Development
• Clinical Research
• Practical application of LLMs
• Cost effective ways to enable AI
• Language models in Pharma

Precision Medicine and Liquid Biopsy

• Manufacturing CAR T cells
• Immuno-oncology
• Multi-cancer early detection
• Personalized medicine for drug safety

Big Data in Oncology

• Clinical biomarkers
• Tumour microenvironment
• Translational data sources
• Analytical and regulatory challenges
• Oncology drug development

Data Management, Storage and Architecture 

• Data platforms 
• FAIR architectures 
• Enterprise data 
• Electronic lab notebook

Analytics Platform

• Data privacy 
• AI/ML driving clinical outcomes 
• Industrializing AI 
• Analytics paradigm

Data Integration + Fair

• Research and development
• Language models
• Silo busting
• Pre and post acquisition

Bioinformatics + Insilico R&D

• Clinical development
• Data driven drug discovery
• Global biologics informatics platforms
• Multi omics

Digital Transformation

• Digital health solutions
• Applications in the life science industry
• Drug development efficiency
• Inclusive data management

Real World Evidence

• Real world data
• Future applications
• Leveraging AI for RWE
• Real world evidence in the clinical setting

Gene Therapy

• Treating genetic disorders with therapy
• CRISPR and gene editing
• Ethical concerns and regulations

Biomarkers + Companion Diagnostics

• Image based machine learning models
• Single molecule detection
• Digital biomarkers
• Multi-cancer early detection

Rare Disease in Genomics

• In-vivo gene editing
• Accelerating medicines for rare diseases
• Neurodevelopmental disorders
• Future of rare diseases